Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension (Phase IIIb)
Conditions
Interventions
Fimasartan 60mg
Fimasartan 120mg
+1 more
Locations
1
South Korea
KyungPook National University Hospital
Daegu, Daegu, South Korea
Start Date
April 1, 2010
Primary Completion Date
April 1, 2011
Completion Date
May 1, 2011
Last Updated
August 24, 2012
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions